Latest News about Fda
Recent news which mentions Fda
Congress's Big Hemp And CBD Debate: Safety Or Profit At Stake?
August 21, 2023
From Benzinga
FDA Approves Regeneron's Drug For Ultra Rare Immune Disorder
August 21, 2023
Tickers
REGN
From Benzinga
FDA Approves Regeneron Pharmaceuticals' Higher Dose Of Eylea For Age-Related Blindness
August 21, 2023
From Benzinga
Legal Psychedelics: Which Compounds Will Be Approved Next? MDMA, LSD Or Something Else?
August 20, 2023
Tickers
MDMA
From Benzinga
FDA Chooses Portable Cannabis Analyzer That Enables Non-Technical Operators To Instantly Test Marijuana Plants & Products
August 18, 2023
From Benzinga
U.S. Hemp Roundtable Members Respond To Congress On CBD Regulations, Here's What They Said
August 16, 2023
From Benzinga
Delcath Systems Stock Soars 90% In One Session - Here's Why
August 15, 2023
Tickers
DCTH
From Benzinga
FDA Gives Green Signal To Arcellx's Stopped Blood Cancer Study
August 15, 2023
Tickers
ACLX
From Benzinga
Logan Paul Challenges Schumer's Scrutiny Of PRIME's Caffeine Content: 'Why Aren't We Controlling This At The Point Of Purchase?'
August 10, 2023
From Benzinga
Lack Of Oversight Continues To Hurt Hemp Industry, What To Expect From 2023 Farm Bill
August 09, 2023
Tickers
HEMP
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.